The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions
Heart Neoplasms
Interventions
PROCEDURE

Echocardiography-guided percutaneous radiofrequency ablation for cardiac tumors

In the parasternal long-axis section, the cardiac puncture guide line was used to locate the puncture, and the best puncture path through the chest wall was selected. The coaxial biopsy needle was punctured through the guide frame, and then through the skin and subcutaneous tissue into the heart tumor tissue to take 2-10 biopsy samples, which were sent for pathological examination. The biopsy needle was extracted, and the radiofrequency electrode needle was punctured along the coaxial sheath to the planned ablation site of the heart tumor. The radiofrequency ablation device was started and the ablation treatment was performed.

Trial Locations (1)

710032

RECRUITING

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER